Prediction of Worsening Heart Failure Events and All-Cause Mortality Using an Individualized Risk Stratification Strategy
Authors:
Open Access
- 28 October 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 7 (6) , 4277-4289
Abstract
Aims This study aimed to examine the clinical utility of a multisensor, remote, ambulatory diagnostic risk score, TriageHF™, in a real‐world, unselected, large patient sample to predict heart failure events (HFEs) and all‐cause mortality. Methods and results TriageHF risk score was calculated in patients in the Optum® database who had Medtronic implantable cardiac defibrillator device from 2007 to 2016. Patients were categorized into three risk groups based on probability for having an HFE within 6 months (low risk P < 0.001, low vs. medium risk, and odds ratio: 9.2, 95% confidence interval: 8.1–10.3, P < 0.001, medium vs. high risk). Findings were similar using the other two analytic strategies. Using a receiver operating characteristic curve analysis, sensitivity for predicting HFE over 30 days using high‐risk score was 47% (alert triggered) and 51% (daily download) vs. 0.5 per patient year unexplained detection rate. TriageHF risk score also predicted all‐cause mortality risk over 4 years. All‐cause mortality risk was 14% in low risk, 20% in medium risk, and 38% in high risk. Conclusions TriageHF risk score provides a multisensor remote, ambulatory diagnostic method that predicts both HFEs and all‐cause mortality.Keywords
Funding Information
- Medtronic
- Medtronic
This publication has 26 references indexed in Scilit:
- Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory settingEuropean Heart Journal, 2013
- Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart FailureCirculation, 2011
- Improved Algorithm to Detect Fluid Accumulation via Intrathoracic Impedance Monitoring in Heart Failure Patients With Implantable DevicesJournal of Cardiac Failure, 2011
- Intrathoracic Impedance vs Daily Weight Monitoring for Predicting Worsening Heart Failure Events: Results of the Fluid Accumulation Status Trial (FAST)Congestive Heart Failure, 2011
- Combined Heart Failure Device Diagnostics Identify Patients at Higher Risk of Subsequent Heart Failure HospitalizationsJACC, 2010
- Changes in Intrathoracic Impedance are Associated With Subsequent Risk of Hospitalizations for Acute Decompensated Heart Failure: Clinical Utility of Implanted Device Monitoring Without a Patient AlertJournal of Cardiac Failure, 2009
- Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart FailureJACC, 2008
- Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failureEuropean Heart Journal, 2007
- Intrathoracic Impedance Monitoring in Patients With Heart FailureCirculation, 2005
- Continuous Autonomic Assessment in Patients With Symptomatic Heart FailureCirculation, 2004